ライフサイエンスコーパス: acute respiratory failure

1 urvival benefits in unselected patients with acute respiratory failure.

2 tracorporeal membrane oxygenation for severe acute respiratory failure.

3 acial mask (oronasal mask) failed to reverse acute respiratory failure.

4 om a Saudi Arabian businessman who died from acute respiratory failure.

5 n it may become the first-line treatment for acute respiratory failure.

6 mbrane oxygenation (ECMO) as a treatment for acute respiratory failure.

7 ow recommended as a definitive treatment for acute respiratory failure.

8 ll-energy enteral nutrition in patients with acute respiratory failure.

9 redisposing condition in patients developing acute respiratory failure.

10 n the context of other salvage therapies for acute respiratory failure.

11 d on extracorporeal membrane oxygenation for acute respiratory failure.

12 mortality compared with other etiologies of acute respiratory failure.

13 cal outcomes in critically ill patients with acute respiratory failure.

14 sary immobilization throughout the course of acute respiratory failure.

15 an important role in managing patients with acute respiratory failure.

16 cal outcomes in morbidly obese patients with acute respiratory failure.

17 ory effort in adult patients recovering from acute respiratory failure.

18 ewed English-language literature on NPPV for acute respiratory failure.

19 ces in the care of infants and children with acute respiratory failure.

20 heostomy in critically injured patients with acute respiratory failure.

21 ranspulmonary pressure (PL) in patients with acute respiratory failure.

22 Four of 5 patients died with acute respiratory failure.

23 ventilated woman with status asthmaticus and acute respiratory failure.

24 of 60-year-old medical patients treated for acute respiratory failure.

25 ated than the oronasal mask in patients with acute respiratory failure.

26 ce of oronasal vs. nasal mask ventilation in acute respiratory failure.

27 dant complications in selected patients with acute respiratory failure.

28 ronic obstructive pulmonary disease who have acute respiratory failure.

29 actively breathing ventilated patients with acute respiratory failure.

30 new tools in the management of patients with acute respiratory failure.

31 ular performance accurately in patients with acute respiratory failure.

32 of respiratory failure and the cause of the acute respiratory failure.

33 oxide (NO) reduces pulmonary hypertension in acute respiratory failure.

34 first 24 h after endotracheal intubation for acute respiratory failure.

35 ty is often important in the pathogenesis of acute respiratory failure.

36 improves outcome in pediatric patients with acute respiratory failure.

37 nnulae are used in adults with or at risk of acute respiratory failure.

38 ning unit, or 3) received a tracheostomy for acute respiratory failure.

39 ll immunocompromised patients with hypoxemic acute respiratory failure.

40 f sedation during mechanical ventilation for acute respiratory failure.

41 ion is used to sustain life in patients with acute respiratory failure.

42 ll immunocompromised patients with hypoxemic acute respiratory failure.

43 xternal hospitals were de novo listed during acute respiratory failure.

44 -saving technique increasingly used to treat acute respiratory failure.

45 U) may improve the outcomes of patients with acute respiratory failure.

46 ng immunocompromised patients with hypoxemic acute respiratory failure.

47 weaning unit, or who had a tracheostomy for acute respiratory failure.

48 eroxia, are frequently used in patients with acute respiratory failure.

49 nt to its use in prevention and treatment of acute respiratory failure.

50 al ventilation has already failed to reverse acute respiratory failure.

51 ren were treated at our center with ECLS for acute respiratory failure 36 (73%) survived.

52 4%-6.3%), cardiogenic shock (0.5%-1.5%), and acute respiratory failure (4.3%-20.8%) from 2001 through

53 ive acute respiratory failure) or to prevent acute respiratory failure (5.3% vs 8.3%; risk ratio=0.64

54 ICU admission was mostly required for acute respiratory failure (62.5%) and/or shock (42.3%).

55 The main indications for ICU admission were acute respiratory failure (89%) and shock (53%).

56 all admissions (n = 524; 50%) were marked by acute respiratory failure, acute kidney injury, or sepsi

57 tracorporeal life support was utilized in 36 acute respiratory failure adult patients with a variety

58 entilation in patients who develop hypoxemic acute respiratory failure after abdominal surgery.

59 These results are relevant to acute respiratory failure after initiation of antibiotic

60 Patients with acute respiratory failure after prolonged neutropenia co

61 Noncardiogenic acute respiratory failure among black Americans increase

62 PATIENTS/Critically ill obese patients with acute respiratory failure and anesthetized swine.

63 performed surgical procedures in adults with acute respiratory failure and identifies a patient cohor

64 erminant of patient outcomes after surviving acute respiratory failure and may be present for months,

65 e death occurred in a 59-year-old woman with acute respiratory failure and mean pulmonary artery pres

66 ruitment and derecruitment of atelectasis in acute respiratory failure and might harm brain tissue in

67 NPPV is successful in reversing acute respiratory failure and preventing hospital mortal

68 evere microscopic polyangiitis can result in acute respiratory failure and renal failure and is commo

69 rk to examine its applicability to trials of acute respiratory failure and severe sepsis.

70 American pediatric intensive care units with acute respiratory failure and suspected influenza virus

71 ive mechanical ventilation failed to reverse acute respiratory failure and, therefore, switched to to

72 s were attributed to treatment (pneumonitis, acute respiratory failure, and cardiovascular failure).

73 os pertaining to treatment of severe sepsis, acute respiratory failure, and general critical care int

74 ltifactorial) origin of acute renal failure, acute respiratory failure, and lower serum urea nitrogen

75 Acute kidney injury, acute respiratory failure, and new-onset subclinical atr

76 Advanced age, acute respiratory failure, and sepsis were the strongest

77 ry complications ranging from atelectasis to acute respiratory failure are common causes of poor peri

78 Diaphragmatic weakness and acute respiratory failure are common in sepsis.

79 tted to intensive care unit (ICU) because of acute respiratory failure (ARF) has not been determined

80 l care (UMC) in the therapy of patients with acute respiratory failure (ARF) in a prospective, random

81 oreal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rap

82 RATIONALE: Research evaluating acute respiratory failure (ARF) survivors' outcomes afte

83 is proposed for treatment for postoperative acute respiratory failure as an alternative to invasive

84 ed noninvasive ventilation or intubation for acute respiratory failure, as compared with 34 (17.0%) a

85 t predictors of mortality with postoperative acute respiratory failure associated with improved survi

86 I, 1.9-11.3; OR, 6.7; 95% CI, 2.1-21.1), and acute respiratory failure (beta coefficient, 6.2; 95% CI

87 predicting outcomes for patients with severe acute respiratory failure but do not predict whether ECM

88 (NPPV) is increasingly used in patients with acute respiratory failure, but few data exist regarding

89 is increasingly applied to prevent or treat acute respiratory failure, but its benefit on survival i

90 tion and analgesic therapy for NPPV to treat acute respiratory failure, but practices vary widely wit

91 otential to improve ventilator management in acute respiratory failure by providing more direct asses

92 Acute respiratory failure, by central and peripheral mec

93 The use of NPPV for patients with acute respiratory failure can be classified into three c

94 at greater risk of developing noncardiogenic acute respiratory failure compared to white Americans.

95 xtubation respiratory failure; patients with acute respiratory failure due to asthma exacerbations, p

96 dary outcomes included time to recovery from acute respiratory failure, duration of weaning from mech

97 itted to the participating institutions with acute respiratory failure during 1991 were included.

98 Acute kidney injury and acute respiratory failure each occurred in 30% of admiss

99 patients admitted to the ICU with hypoxemic acute respiratory failure, early noninvasive ventilation

100 In patients in acute respiratory failure, elevated esophageal pressures

101 Acute respiratory failure etiologies were mostly pneumon

102 st common, were included when they developed acute respiratory failure (failure of a spontaneous brea

103 In patients in hypercapnic acute respiratory failure, for whom escalation to intuba

104 Six presented with acute respiratory failure, four requiring mechanical ven

105 with extracorporeal membrane oxygenation for acute respiratory failure from 1993 to 2007.

106 mmatory events in the airways at the time of acute respiratory failure from acute severe asthma are p

107 cting successful extubation in children with acute respiratory failure from lower respiratory tract d

108 In children with acute respiratory failure from lower respiratory tract d

109 mined ICU use and outcomes for patients with acute respiratory failure from PCP from 1995 to 1997.

110 rtality, whereas patients with postoperative acute respiratory failure had the best survival rate.

111 Patients with interstitial lung disease and acute respiratory failure have a poor prognosis especial

112 illatory ventilation (HFOV) in children with acute respiratory failure have not been established.

113 In immunocompromised patients with hypoxemic acute respiratory failure, high-flow nasal oxygen when c

114 The main reason for ICU admission was acute respiratory failure in 111 patients (81.6%), of wh

115 Data were recorded on 137 episodes of acute respiratory failure in 131 DNI patients.

116 Severe acute respiratory failure in adults causes high mortalit

117 Recent studies in the treatment of acute respiratory failure in children have been targeted

118 frequency oscillatory ventilation (HFOV) for acute respiratory failure in children is prevalent despi

119 Acute respiratory failure in hematological patients is r

120 ith increasing frequency in the treatment of acute respiratory failure in pediatric patients.

121 Acute respiratory failure in term and near term infants

122 The incidence of noncardiogenic acute respiratory failure in the United States increased

123 ine trends in the race-specific incidence of acute respiratory failure in the United States.

124 character of mobility for ICU patients with acute respiratory failure in U.S.

125 e Americans, the incidence of noncardiogenic acute respiratory failure increased from 31.2 (95% confi

126 Annual cases of noncardiogenic acute respiratory failure increased from 86,755 in 1992

127 In immunocompromised patients with acute respiratory failure, invasive mechanical ventilati

128 g and prevent complications in patients with acute respiratory failure is actively debated, with many

129 arly HFOV compared with CMV in children with acute respiratory failure is associated with worse outco

130 In preterm infants, the most common cause of acute respiratory failure is respiratory distress syndro

131 Acute respiratory failure is the most common problem see

132 The incidence of influenza-associated acute respiratory failure is unknown.

133 of noninvasive respiratory support (NRS) in acute respiratory failure, it is likewise likely to also

134 In patients recovering from acute respiratory failure, levels of neurally adjusted v

135 dy to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) was an internation

136 dy to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE).

137 Acute respiratory failure, major cardiac complications,

138 CT, organ dysfunction score, cardiac arrest, acute respiratory failure, malignant organ infiltration,

139 ory distress syndrome (ARDS) is a disease of acute respiratory failure manifested by severe hypoxemia

140 ose with complex comorbid diseases including acute respiratory failure may be better treated with IVI

141 Ambulation of patients with acute respiratory failure may be unnecessarily limited i

142 eously breathing, nonintubated patients with acute respiratory failure may have a high respiratory dr

143 The majority of patients had acute respiratory failure, multiple organ system failure

144 al face mask included refractory hypercapnic acute respiratory failure (n = 24, 66.7%), painful skin

145 poreal membrane oxygenation in patients with acute respiratory failure; none reported specifically on

146 s of extracorporeal membrane oxygenation for acute respiratory failure of all etiologies, among which

147 noninvasive ventilation outside the ICU for acute respiratory failure of heterogeneous causes and to

148 obstructive pulmonary disease exacerbation, acute respiratory failure of mixed etiologies, and posto

149 en a previously healthy person presents with acute respiratory failure of unknown origin.

150 % CI, 2.12-5.15) compared with patients with acute respiratory failure or multiple organ system failu

151 ilure of mixed etiologies, and postoperative acute respiratory failure) or to prevent acute respirato

152 e average annual incidence of noncardiogenic acute respiratory failure over the entire study period w

153 on of the effects of inhaled nitric oxide in acute respiratory failure patients continues to show tra

154 Transfer of acute respiratory failure patients to the respiratory in

155 In acute respiratory failure patients undergoing pressure s

156 In a cohort of hospitals caring for acute respiratory failure patients, physical therapy/occ

157 generates the hypothesis that in ventilated acute respiratory failure patients, Sigh may enhance reg

158 patients with interstitial lung disease and acute respiratory failure provided they are candidates f

159 imated 400,000 patients who annually develop acute respiratory failure, require endotracheal intubati

160 Acute respiratory failure requiring mechanical ventilati

161 critically ill patients including those with acute respiratory failure requiring mechanical ventilati

162 al volume loss is common among patients with acute respiratory failure requiring mechanical ventilati

163 The incidence of acute respiratory failure requiring mechanical ventilati

164 Adult patients (>/= 18 yr old) with acute respiratory failure requiring mechanical ventilati

165 years; women, 55%) admitted to the ICU with acute respiratory failure requiring mechanical ventilati

166 that extracorporeal membrane oxygenation for acute respiratory failure resulting from viral pneumonia

167 Severe H1N1 pneumonia with acute respiratory failure results in infiltration of lun

168 mes in mechanically ventilated patients with acute respiratory failure similar to those of early full

169 Mycophenolate mofetil can cause acute respiratory failure simulating opportunistic infec

170 Among patients hospitalized with acute respiratory failure, SRT compared with usual care

171 dy to Understand the Global Impact of Severe Acute Respiratory Failure) study described the managemen

172 Overall survival of pediatric patients with acute respiratory failure supported by VA or VV ECLS was

173 apy and mobilization goals for patients with acute respiratory failure supported by venovenous extrac

174 acute respiratory distress syndrome (ARDS); acute respiratory failure; surfactant deficiency; saline

175 in all clinical research studies evaluating acute respiratory failure survivors after hospital disch

176 research studies evaluating the outcomes of acute respiratory failure survivors after hospital disch

177 s and 2) results from a qualitative study of acute respiratory failure survivors' outcomes after hosp

178 esults from surveys of clinical researchers, acute respiratory failure survivors, and caregivers that

179 esearch evaluating postdischarge outcomes of acute respiratory failure survivors: clinical researcher

180 ess syndrome (ARDS) is an important cause of acute respiratory failure that is often associated with

181 ible underlying diseases resulting in severe acute respiratory failure that is unresponsive to conven

182 y distress syndrome (ARDS), are syndromes of acute respiratory failure that result from acute pulmona

183 ildren undergoing mechanical ventilation for acute respiratory failure, the use of a sedation protoco

184 ly accepted treatment for some patients with acute respiratory failure, the use of NPPV in patients w

185 nt for at least 2 wks following the onset of acute respiratory failure to insure need for ongoing ven

186 rting the use of noninvasive ventilation for acute respiratory failure to prevent intubation in patie

187 Adult patients with severe acute respiratory failure treated by ECMO from 2000 to 2

188 ough the survival of pediatric patients with acute respiratory failure treated with extracorporeal me

189 or intubation was detected in patients with acute respiratory failure treated with high-flow nasal c

190 of immunocompromised patients with hypoxemic acute respiratory failure treated with high-flow nasal o

191 Six (15%) developed acute respiratory failure treated with invasive mechanic

192 In severe acute respiratory failure treated with lung rest and ext

193 patients with interstitial lung disease and acute respiratory failure treated with or without ECMO f

194 tion on gas exchange in children with severe acute respiratory failure unresponsive to conventional v

195 The incidence of influenza-associated acute respiratory failure was 2.7 per 100,000 person-yea

196 acorporeal membrane oxygenation in pediatric acute respiratory failure was completed in 1993.

197 right ventricular function in patients with acute respiratory failure was determined by assessing th

198 ter assessment of baseline physiologic data, acute respiratory failure was induced by right atrial in

199 ncidence rate ratio for influenza-associated acute respiratory failure was lower among children aged

200 Sepsis, acute kidney injury, and acute respiratory failure were associated with mortality

201 eks to 17 years) mechanically ventilated for acute respiratory failure were enrolled in 2009-2013 and

202 , 38 patients with severe H1N1 pneumonia and acute respiratory failure were enrolled.

203 ease referred to our intensive care unit for acute respiratory failure were included in the analysis.

204 aged 1 month to 18 yrs who received ECLS for acute respiratory failure were included.

205 All patients receiving NPPV for acute respiratory failure were screened and enrolled if

206 cember 2004, 50 morbidly obese patients with acute respiratory failure were treated with mechanical v

207 Hyperoxia can exacerbate acute respiratory failure, which has high mortality and

208 ty-four patients mechanically ventilated for acute respiratory failure with esophageal balloons place

209 All patients were treated for acute respiratory failure with titrated levels of positi

210 ypothesized that ambulation of patients with acute respiratory failure would increase with transfer t